Pharmacological treatments for alcohol dependence: evidence on uptake, inequalities and comparative effectiveness from a UK population-based cohort

Francesco Manca, Lisong Zhang, Niamh Fitzgerald, Frederick Ho, Hamish Innes, Bhautesh Jani, Srinivasa Vittal Katikireddi, Andrew McAuley, Clare Sharp, Jim Lewsey*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
71 Downloads (Pure)

Abstract

Introduction: We assessed the prevalence of prescribing of certain medications for alcohol dependence and the extent of any inequalities in receiving prescriptions for individuals with such a diagnosis. Further, we compared the effectiveness of two of the most prescribed medications (acamprosate and disulfiram) for alcohol dependence and assessed whether there is inequality in prescribing either of them. Methods: We used a nationwide dataset on prescriptions and hospitalisations in Scotland, UK (N = 19,748). We calculated the percentage of patients receiving alcohol dependence prescriptions after discharge, both overall and by socio-economic groups. Binary logistic regressions were used to assess the odds of receiving any alcohol-dependence prescription and the comparative odds of receiving acamprosate or disulfiram. Comparative effectiveness in avoiding future alcohol-related hospitalisations (N = 11,239) was assessed using Cox modelling with statistical adjustment for potential confounding. Results: Upto 7% of hospitalised individuals for alcohol use disorder received prescriptions for alcohol dependence after being discharged. Least deprived socio-economic groups had relatively more individuals receiving prescriptions. Inequalities in prescribing for alcohol dependence existed, especially across sex and comorbidities: males had 12% (odds ratio [OR] 0.88, 95% confidence interval [CI] 0.81–0.96) and those with a history of mental health hospitalisations had 10% (OR 0.90, 95% CI 0.82–0.98) lower odds of receiving prescriptions after an alcohol-related hospitalisation. Prescribing disulfiram was superior to prescribing acamprosate in preventing alcohol-related hospitalisations (hazard ratio ranged between 0.60 and 0.81 across analyses). Disulfiram was relatively less likely prescribed to those from more deprived areas. Discussion and Conclusions: Inequalities in prescribing for alcohol dependence exists in Scotland with lower prescribing to men and disulfiram prescribed more to those from least deprived areas.

Original languageEnglish
Pages (from-to)1183-1193
Number of pages11
JournalDrug and Alcohol Review
Volume43
Issue number5
Early online date23 Apr 2024
DOIs
Publication statusPublished - Jul 2024

Keywords

  • acamprosate
  • alcohol dependence
  • comparative effectiveness
  • disulfiram
  • inequality

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health(social science)

Fingerprint

Dive into the research topics of 'Pharmacological treatments for alcohol dependence: evidence on uptake, inequalities and comparative effectiveness from a UK population-based cohort'. Together they form a unique fingerprint.

Cite this